President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

TGCHE and BDMAI sign MoU to bridge academia-pharma industry skill gap, aligning education with industry needs for workforce development.

Ardena's drug product manufacturing facility in Somerset Advanced drug product manufacturing facility acquired by Ardena in ...

Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.rPymOukO.js ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

This outsourcing arrangement allows pharmaceutical companies to delegate the complex and capital-intensive tasks of drug development and manufacturing, enabling them to focus on their core ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...